These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 25599386

  • 1. Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas.
    Duparc C, Moreau L, Dzib JF, Boyer HG, Tetsi Nomigni M, Boutelet I, Boulkroun S, Mukai K, Benecke AG, Amar L, Gobet F, Meatchi T, Plouin PF, Zennaro MC, Louiset E, Lefebvre H.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E550-60. PubMed ID: 25599386
    [Abstract] [Full Text] [Related]

  • 2. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
    Lenzini L, Caroccia B, Campos AG, Fassina A, Belloni AS, Seccia TM, Kuppusamy M, Ferraro S, Skander G, Bader M, Rainey WE, Rossi GP.
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684
    [Abstract] [Full Text] [Related]

  • 3. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.
    Cartier D, Jégou S, Parmentier F, Lihrmann I, Louiset E, Kuhn JM, Bastard C, Plouin PF, Godin M, Vaudry H, Lefebvre H.
    Eur J Endocrinol; 2005 Dec; 153(6):939-47. PubMed ID: 16322401
    [Abstract] [Full Text] [Related]

  • 4. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.
    Saner-Amigh K, Mayhew BA, Mantero F, Schiavi F, White PC, Rao CV, Rainey WE.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
    De Sousa K, Abdellatif AB, Giscos-Douriez I, Meatchi T, Amar L, Fernandes-Rosa FL, Boulkroun S, Zennaro MC.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):419-434. PubMed ID: 34570225
    [Abstract] [Full Text] [Related]

  • 7. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
    Peng KY, Chang HM, Lin YF, Chan CK, Chang CH, Chueh SJ, Yang SY, Huang KH, Lin YH, Wu VC, Wu KD.
    J Clin Endocrinol Metab; 2018 Oct 01; 103(10):3737-3747. PubMed ID: 30085132
    [Abstract] [Full Text] [Related]

  • 8. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
    Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B.
    J Clin Endocrinol Metab; 2014 Jul 01; 99(7):E1341-51. PubMed ID: 24758183
    [Abstract] [Full Text] [Related]

  • 9. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
    Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE.
    J Endocrinol; 2007 Oct 01; 195(1):39-48. PubMed ID: 17911395
    [Abstract] [Full Text] [Related]

  • 10. The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas.
    Takeda Y, Usukura M, Yoneda T, Oda N, Ito Y, Mabuchi H.
    Clin Endocrinol (Oxf); 2005 Apr 01; 62(4):504-8. PubMed ID: 15807884
    [Abstract] [Full Text] [Related]

  • 11. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A, Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M.
    J Clin Endocrinol Metab; 2013 Apr 01; 98(4):1567-74. PubMed ID: 23443813
    [Abstract] [Full Text] [Related]

  • 12. Disordered CYP11B2 Expression in Primary Aldosteronism.
    Gomez-Sanchez CE, Kuppusamy M, Reincke M, Williams TA.
    Horm Metab Res; 2017 Dec 01; 49(12):957-962. PubMed ID: 29202495
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T, Nakajima Y, Katano-Toki A, Horiguchi K, Matsumoto S, Yoshino S, Yamada E, Tomaru T, Ishii S, Saito T, Ozawa A, Shibusawa N, Satoh T, Okada S, Nagaoka R, Takada D, Horiguchi J, Oyama T, Yamada M.
    Endocr J; 2017 Jan 30; 64(1):39-47. PubMed ID: 27681703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.
    Itcho K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, Kobuke K, Nagano G, Yoshii Y, Baba R, Hattori N, Yoneda M.
    Hypertension; 2020 Feb 30; 75(2):492-499. PubMed ID: 31865789
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).
    Teo AE, Garg S, Johnson TI, Zhao W, Zhou J, Gomez-Sanchez CE, Gurnell M, Brown MJ.
    Hypertension; 2017 Jun 30; 69(6):1207-1216. PubMed ID: 28416583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
    Guo Z, Nanba K, Udager A, McWhinney BC, Ungerer JPJ, Wolley M, Thuzar M, Gordon RD, Rainey WE, Stowasser M.
    J Clin Endocrinol Metab; 2020 Sep 01; 105(9):e3224-35. PubMed ID: 32516371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.